SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial

Name: SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial
Published: 2020
License: Public Domain

M.D. Anderson Cancer Center · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

metastatic colon adenocarcinoma, metastatic colorectal carcinoma, metastatic rectal adenocarcinoma, stage iii colon cancer ajcc v8, stage iii rectal cancer ajcc v8, stage iiia colon cancer ajcc v8, stage iiia rectal cancer ajcc v8, stage iiib colon cancer ajcc v8, stage iiib rectal cancer ajcc v8, stage iiic colon cancer ajcc v8, stage iiic rectal cancer ajcc v8, stage iv colon cancer ajcc v8

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 1029810
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.